Preparing the Workforce That Will Shape Pharma’s Future with ISPE President & CEO Mike Martin

About this episode

Nick Capman interviews Mike Martin about the future of workforce development in the pharmaceutical industry amidst technological changes.

The FDA Group's Nick Capman sits down with Mike Martin , President and CEO of ISPE, for a conversation on how the pharmaceutical industry must rethink workforce development amid rapid technological and cultural change. Drawing on nearly four decades of global experience in pharmaceutical engineering, operations, and manufacturing leadership, Mike shares his perspective on why the industry is entering a new industrial era — often referred to as Pharma 4.0 — and what that means for engineers, operators, and leaders at every level. The discussion explores how automation, robotics, and AI are reshaping day-to-day work, why deep technical expertise remains critical in an AI-driven environment, and how organizations must move beyond reactive reskilling toward more intentional “pre-skilling” of future talent. Mike also reflects on the enduring importance of character, integrity, curiosity, and trust, arguing that these traits matter as much as technical competence in a highly regulated industry. Nick and Mike examine the evolving role of professional organizations like ISPE in building global communities of practice, sharing knowledge across borders, and supporting lifelong learning…

People in this episode

Host: Nick Capman

Guest: Mike Martin

Topics covered

• workforce development
• pharmaceutical industry
• automation
• AI
• professional organizations
• education
• Pharma 4.0

Keywords

• workforce
• pharmaceutical engineering
• automation
• AI
• reskilling
• pre-skilling
• professional organizations
• education
• Pharma 4.0

Mentioned in this episode

Organizations: ISPE, Pharma 4.0

More episodes of The Life Science Rundown

• TerSera's VP of Quality on the Audit Risk Hiding Inside Your Own Procedures · May 18, 2026 · 31 min
• What Auditors Are Actually Looking For — and the Psychology Behind How They Find It · April 28, 2026 · 20 min
• Why Kidney Disease Innovation Is a Tale of Two Cities — and What It Would Take to Change That · April 10, 2026 · 35 min
• Syncing Global Regulatory Filings Across FDA, EMA, and PMDA with AJ Acker · March 30, 2026 · 29 min
• Navigating Regulatory Leadership Across Large and Small Life Science with Tammy Sarnelli · March 19, 2026 · 33 min
• Getting Data Governance for Regulatory Submissions Right Before AI Gets it Wrong with Cary Smithson · March 5, 2026 · 28 min